Navigation Links
Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
Date:1/18/2008

REDWOOD CITY, Calif., Jan. 18 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal second quarter ended December 31, 2007 on Thursday, January 24, 2008 after the markets close, and the company's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.

Conference Call Details

To access the live conference call on January 24, 2008 at 4:30 p.m. Eastern Time via phone, please dial 800-659-1966 the United States and Canada or +1-617-614-2711 internationally. The conference ID is 37076673. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through January 31, 2008 and may be accessed by dialing 888-286-8010 from the United States and Canada or +1-617-801-6888 internationally. The replay passcode is 33900859.

To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of Cardica's website at http://www.cardica.com. Please connect to the website at least 15 minutes prior to the call to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a passwo
'/>"/>

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cardica Announces Proposed Public Offering of Common Stock
2. Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock
3. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
4. Cardica Announces Exercise of Over-Allotment Option
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. HEI, Inc. Announces Sale of RFID Division Assets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Z Trim Announces Revocation of Gregory Halpern Severence Agreement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...ndCALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc....I)coilsandsoftwareandCalgaryScientificInc.,aleadin...ucedawebversionofAegis(TM)Breast4DAdvancedVisualiz...irsttrulyzero-footprintWebclientbasedmedicalimagin...)platformallowsforzero-footprintaccess-requiringno...
(Date:11/25/2009)...ISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManag...pare the Air Alert forThursday,November...anyothersolidfuel,bothindoorsandoutdoors. ,, "C...ytomorrow,"saidJackBroadbent,executiveofficerofthe...hehealthoftheirneighborsandfellowcommunitymemberst...
(Date:11/25/2009)...crease blood pressure? This simple question has b... New Stress-related gene Modulates High Blood Pres...essure? This simple question has been the focus o...ch has for the first time established a link betwe... response to stress in mice as well as humans. The...
(Date:11/25/2009)...plagued by neurological symptoms, study finds , ...Neurological side effects are among the potential ...r cancer who were treated with cisplatin-based che...ncluded 1,409 Norwegian men treated for unilateral...part in a follow-up survey conducted from 1998 to ...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...ern Medical College at Dallas report that contact ...xygen transmissible materials are expected to redu...han contact lenses which are available now. Based ...ar.// The results of the Southeastern study ar...
...he hair loss associated with drug treatment for ca...apy-induced alopecia (CIA), is a frequent side eff...g for patients at a vulnerable time in their lives...s with a skull cap to cool the scalp, minimising b...
...ion that is to blame for most panic attacks and ot...breakthrough could lead to the development of drug...ated that more than one in twelve people suffer fr...hobia. They found that 92% of the affected family ...
...rst clues to the high failure rate of cloning and ...ore of the nucleus.The discovery, announced at the...e Advancement of Science in Washington, shows that...ogether.// "Our genes are not uniformly distr...
...lder people avert a form of arthritis that can cha...lking an impossible one.Those who regularly walked...bilities to perform activities of daily living. ...elying on others for help// in these ordinary acti...
...screening technique for persons suffering from typ...rch Fund says investigations of skin lesions may a...rom a group of cancers, particularly those of the ...yposis colorectal cancer syndrome - it may be poss...
Other Medicine News:Health News:New contact lens materials 2Health News:Breakthrough in cancer therapy 2Health News:The anxiety gene, 2Health News:DNA and clones 2Health News:Arthritis risk reduced by exercise 2
(Date:11/25/2009)...25/PRNewswire-FirstCall/--HeskaCorporation(HSKA);(...specialtyproductstotheveterinaryindustry,announced...hesupplyofbloodgasproductsandaffiliatedconsumables...wscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ...efieldofadvancedpoint-of-carediagnostics,"commente...
(Date:11/25/2009)...Newswire/--BioTrendsResearchGroup,Inc.releasedWave...rstinamulti-phasesyndicatedmarketresearchprojecttr...omproductlaunchthroughthefirstsixmonthsofavailabil...tionfrom75uniqueDermatologistsandqualitativeinform...Stelara,obstaclestouse,typicalpatienttypes,product...
(Date:11/25/2009)...ov.25/PRNewswire/--RegadoBiosciences,aprivatelyhel...erswithactivecontrolagents,announcedthatDavidMazzo...fray21stAnnualHealthCareConferenceattheNewYorkPala...ivenat1:10pm(EST)onTuesday,December1andwillinclude...eaddevelopmentprogram,theanticoagulantsystem,REG1....
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 1Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 2Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 1Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 1ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 3ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 4ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 5ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 6ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 7ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 8ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 9ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 10ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 11
...AM, England, October 7 ,Sosei Group Corporation ("... plc ("Vectura"; LSE: VEC), announce results of tw... and tolerability of NVA237 presented at the,annua...S) in Berlin,Germany. The new data show that NVA23...cting muscarinic antagonist (LAMA), provides susta...
...pens the door to the understanding of and possible... and cancer, BILLERICA, Mass., Oct. 6 Seahorse B... ever analytical instrument for the,kinetic measur...plasmic,glycolysis in cells in a 96 well microplat...lar bioenergetics have been relatively unchanged s...
Other Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3
STELLARA™
...m Thermo Labsystems was designed specifically to c... Advanced features such as the new fast dial syst...es help to define this as a new leader in single c...ate offers a custom fit for different hand sizes. ...
Corning Lambda Single Channel Pipettor, 0.1-2.5 ul
...s improved ergonomics for today's exacting laborat...finger rest and the large display windows enhance ...als also feature soft-touch tip ejection with powe... blow-out for 0.2 - 50ul micro volume pipetting. F...
Medicine Products: